Atai Life Sciences N.V. (NQ: ATAI )
1.170
-0.050
(-4.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Headline News about Atai Life Sciences N.V.
![](https://cdn.benzinga.com/files/images/story/2024/08/14/2-5.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/31/image006.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2020/05/psychedelics-3.jpg)
![](https://investorplace.com/wp-content/uploads/2020/10/psychedelic-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/05/psychedelics-3.jpg)
![](https://investorplace.com/wp-content/uploads/2020/10/psychedelic-stocks-a-1600.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/05/US-Psychedelic-Law-Acontent-creator-and-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2024/06/05/financial-psychedelics-Raimundo79-and-Bl.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/09/picture20.jpeg?width=1200&height=800&fit=crop)
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2024/04/19/Jim-Cramer-Photo-by-s-bukley-on-Shutters.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/17/Psyched.png?width=1200&height=800&fit=crop)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.pixabay.com/photo/2015/07/11/00/38/chart-840331_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/03/ulta_beauty_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/03/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2015/07/11/00/38/chart-840331_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/fabian-blank-pElSkGRA2NU-unsplash.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/MeO-DMT-Nynke-van-Holten-on-Shutterstock.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.